Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Research

Projected estimates of cancer in Canada in 2020

Darren R. Brenner, Hannah K. Weir, Alain A. Demers, Larry F. Ellison, Cheryl Louzado, Amanda Shaw, Donna Turner, Ryan R. Woods and Leah M. Smith; for the Canadian Cancer Statistics Advisory Committee
CMAJ March 02, 2020 192 (9) E199-E205; DOI: https://doi.org/10.1503/cmaj.191292
Darren R. Brenner
Departments of Oncology and Community Health Sciences (Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Division of Cancer Prevention and Control (Weir), Centers for Disease Control and Prevention, Atlanta, Ga.; Centre for Surveillance and Applied Research (Demers, Shaw), Public Health Agency of Canada; Centre for Population Health Data (Ellison), Statistics Canada, Ottawa, Ont.; Data Linkage and Integration (Louzado), Canadian Partnership Against Cancer, Toronto, Ont.; Population Oncology (Turner), CancerCare Manitoba, Winnipeg, Man.; Population Oncology (Woods), BC Cancer, Vancouver, BC; Canadian Cancer Society (Smith), St. John’s, N.L.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hannah K. Weir
Departments of Oncology and Community Health Sciences (Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Division of Cancer Prevention and Control (Weir), Centers for Disease Control and Prevention, Atlanta, Ga.; Centre for Surveillance and Applied Research (Demers, Shaw), Public Health Agency of Canada; Centre for Population Health Data (Ellison), Statistics Canada, Ottawa, Ont.; Data Linkage and Integration (Louzado), Canadian Partnership Against Cancer, Toronto, Ont.; Population Oncology (Turner), CancerCare Manitoba, Winnipeg, Man.; Population Oncology (Woods), BC Cancer, Vancouver, BC; Canadian Cancer Society (Smith), St. John’s, N.L.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alain A. Demers
Departments of Oncology and Community Health Sciences (Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Division of Cancer Prevention and Control (Weir), Centers for Disease Control and Prevention, Atlanta, Ga.; Centre for Surveillance and Applied Research (Demers, Shaw), Public Health Agency of Canada; Centre for Population Health Data (Ellison), Statistics Canada, Ottawa, Ont.; Data Linkage and Integration (Louzado), Canadian Partnership Against Cancer, Toronto, Ont.; Population Oncology (Turner), CancerCare Manitoba, Winnipeg, Man.; Population Oncology (Woods), BC Cancer, Vancouver, BC; Canadian Cancer Society (Smith), St. John’s, N.L.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Larry F. Ellison
Departments of Oncology and Community Health Sciences (Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Division of Cancer Prevention and Control (Weir), Centers for Disease Control and Prevention, Atlanta, Ga.; Centre for Surveillance and Applied Research (Demers, Shaw), Public Health Agency of Canada; Centre for Population Health Data (Ellison), Statistics Canada, Ottawa, Ont.; Data Linkage and Integration (Louzado), Canadian Partnership Against Cancer, Toronto, Ont.; Population Oncology (Turner), CancerCare Manitoba, Winnipeg, Man.; Population Oncology (Woods), BC Cancer, Vancouver, BC; Canadian Cancer Society (Smith), St. John’s, N.L.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cheryl Louzado
Departments of Oncology and Community Health Sciences (Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Division of Cancer Prevention and Control (Weir), Centers for Disease Control and Prevention, Atlanta, Ga.; Centre for Surveillance and Applied Research (Demers, Shaw), Public Health Agency of Canada; Centre for Population Health Data (Ellison), Statistics Canada, Ottawa, Ont.; Data Linkage and Integration (Louzado), Canadian Partnership Against Cancer, Toronto, Ont.; Population Oncology (Turner), CancerCare Manitoba, Winnipeg, Man.; Population Oncology (Woods), BC Cancer, Vancouver, BC; Canadian Cancer Society (Smith), St. John’s, N.L.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda Shaw
Departments of Oncology and Community Health Sciences (Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Division of Cancer Prevention and Control (Weir), Centers for Disease Control and Prevention, Atlanta, Ga.; Centre for Surveillance and Applied Research (Demers, Shaw), Public Health Agency of Canada; Centre for Population Health Data (Ellison), Statistics Canada, Ottawa, Ont.; Data Linkage and Integration (Louzado), Canadian Partnership Against Cancer, Toronto, Ont.; Population Oncology (Turner), CancerCare Manitoba, Winnipeg, Man.; Population Oncology (Woods), BC Cancer, Vancouver, BC; Canadian Cancer Society (Smith), St. John’s, N.L.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donna Turner
Departments of Oncology and Community Health Sciences (Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Division of Cancer Prevention and Control (Weir), Centers for Disease Control and Prevention, Atlanta, Ga.; Centre for Surveillance and Applied Research (Demers, Shaw), Public Health Agency of Canada; Centre for Population Health Data (Ellison), Statistics Canada, Ottawa, Ont.; Data Linkage and Integration (Louzado), Canadian Partnership Against Cancer, Toronto, Ont.; Population Oncology (Turner), CancerCare Manitoba, Winnipeg, Man.; Population Oncology (Woods), BC Cancer, Vancouver, BC; Canadian Cancer Society (Smith), St. John’s, N.L.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryan R. Woods
Departments of Oncology and Community Health Sciences (Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Division of Cancer Prevention and Control (Weir), Centers for Disease Control and Prevention, Atlanta, Ga.; Centre for Surveillance and Applied Research (Demers, Shaw), Public Health Agency of Canada; Centre for Population Health Data (Ellison), Statistics Canada, Ottawa, Ont.; Data Linkage and Integration (Louzado), Canadian Partnership Against Cancer, Toronto, Ont.; Population Oncology (Turner), CancerCare Manitoba, Winnipeg, Man.; Population Oncology (Woods), BC Cancer, Vancouver, BC; Canadian Cancer Society (Smith), St. John’s, N.L.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leah M. Smith
Departments of Oncology and Community Health Sciences (Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.; Division of Cancer Prevention and Control (Weir), Centers for Disease Control and Prevention, Atlanta, Ga.; Centre for Surveillance and Applied Research (Demers, Shaw), Public Health Agency of Canada; Centre for Population Health Data (Ellison), Statistics Canada, Ottawa, Ont.; Data Linkage and Integration (Louzado), Canadian Partnership Against Cancer, Toronto, Ont.; Population Oncology (Turner), CancerCare Manitoba, Winnipeg, Man.; Population Oncology (Woods), BC Cancer, Vancouver, BC; Canadian Cancer Society (Smith), St. John’s, N.L.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • Figure 1:
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1:

    Age-standardized incidence rates (ASIRs) for selected cancers, in Canada (excluding Quebec), 1984–2020, by sex. Shading indicates projected data.

  • Figure 2:
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2:

    Age-standardized mortality rates (ASMRs) for selected cancers in Canada, 1984–2020, by sex. Shading indicates projected data.

Tables

  • Figures
    • View popup
    Table 1:

    Projected estimates of new cases and age-standardized incidence rates for cancers in Canada in 2020, by sex

    Type of cancerNo. of new casesASIR*
    Total†MalesFemalesIn both sexesMalesFemales
    All cancers‡225 800115 800110 000519.4557.8491.2
    Lung and bronchus29 80015 00014 80061.464.859.3
    Breast27 70024027 40066.91.1128.2
    Colorectal26 90014 90012 00060.571.550.8
    Prostate23 30023 300NANA116.7NA
    Bladder§12 2009400280025.042.010.7
    Non-Hodgkin lymphoma10 4005800450024.429.320.2
    Thyroid86002300640022.511.733.1
    Melanoma80004400360021.825.219.2
    Kidney and renal pelvis75004900260017.323.611.5
    Uterus (body, NOS)7400NA7400NANA35.0
    Leukemia69004100280016.521.112.6
    Pancreas60003100290013.014.211.8
    Oral54003700165012.818.57.5
    Stomach4200270014509.413.16.1
    Multiple myeloma3400200014507.89.76.1
    Ovary3100NA3100NANA14.2
    Liver310023008106.810.63.3
    Brain/CNS3000170013507.18.35.9
    Esophagus240018505505.79.32.4
    Cervix1350NA1350NANA7.1
    Testis11501150NANA6.5NA
    Larynx11509801802.34.10.7
    Hodgkin lymphoma10005704402.62.92.3
    All other cancers21 80011 30010 50047.553.243.2
    • Note: ASIR = age-standardized incidence rate, CNS = central nervous system, NOS = not otherwise specified, NA = not applicable.

    • ↵* Rates exclude those from Quebec.

    • ↵† Column total may not sum to row totals owing to rounding.

    • ↵‡ All cancers excludes nonmelanoma skin cancers (neoplasms, NOS; epithelial neoplasms, NOS; and basal and squamous).

    • ↵§ Bladder cancer includes in situ carcinomas.

    • View popup
    Table 2:

    Projected estimates of deaths and age-standardized mortality rates for cancers in Canada in 2020, by sex

    Type of cancerNo. of deathsASMR
    Total*MalesFemalesBoth sexesMalesFemales
    All cancers83 30044 10039 300188219.7164.2
    Lung and bronchus21 20011 00010 20047.253.442.5
    Colorectal97005300440021.826.418.0
    Pancreas53002700260012.013.510.7
    Breast510055510011.90.322.0
    Prostate42004200NANA21.8NA
    Leukemia3000180012506.99.05.2
    Non-Hodgkin lymphoma2900160012506.58.15.1
    Bladder260018507205.79.62.8
    Brain/CNS2500140010505.87.14.7
    Esophagus230017505105.18.62.1
    Ovary1950NA1950NANA8.3
    Stomach195012007604.56.03.2
    Kidney and renal pelvis195013006804.46.42.8
    Multiple myeloma16008807003.54.42.8
    Oral150010504403.55.31.8
    Liver†145011502903.25.51.2
    Uterus (body, NOS)1300NA1300NANA5.4
    Melanoma13008704503.14.42.0
    Cervix410NA410NANA2.0
    Larynx400330750.91.60.3
    Thyroid2301101300.50.50.5
    Hodgkin lymphoma10065400.20.30.2
    Testis3535NANA0.2NA
    All other cancers10 4005400500023.527.320.5
    • Note: ASMR = age-standardized mortality rate, CNS = central nervous system, ICD-10 = International Statistical Classification of Diseases and Related Health Problems, 10th Revision, NA = not applicable, NOS = not otherwise specified.

    • ↵* Column total may not sum to row totals owing to rounding.

    • ↵† Liver cancer mortality was underestimated because deaths from liver cancer, unspecified (ICD-10 code C22.9) were excluded.

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 192 (9)
CMAJ
Vol. 192, Issue 9
2 Mar 2020
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Projected estimates of cancer in Canada in 2020
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Projected estimates of cancer in Canada in 2020
Darren R. Brenner, Hannah K. Weir, Alain A. Demers, Larry F. Ellison, Cheryl Louzado, Amanda Shaw, Donna Turner, Ryan R. Woods, Leah M. Smith
CMAJ Mar 2020, 192 (9) E199-E205; DOI: 10.1503/cmaj.191292

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Projected estimates of cancer in Canada in 2020
Darren R. Brenner, Hannah K. Weir, Alain A. Demers, Larry F. Ellison, Cheryl Louzado, Amanda Shaw, Donna Turner, Ryan R. Woods, Leah M. Smith
CMAJ Mar 2020, 192 (9) E199-E205; DOI: 10.1503/cmaj.191292
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Interpretation
    • Footnotes
    • References
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Avancees dans la prise en charge de ladenocarcinome canalaire pancreatique
  • Innovations in cancer immunotherapy: chimeric antigen receptor T-cell therapy (CAR-T)
  • Negative impact of COVID-19 associated health system shutdown on patients diagnosed with colorectal cancer: a retrospective study from a large tertiary center in Ontario, Canada
  • Breast Cancer Survival in Multiple Sclerosis: A Matched Cohort Study
  • Advances in the management of pancreatic ductal adenocarcinoma
  • Association between antihypertensive medications and risk of skin cancer in people older than 65 years: a population-based study
  • Depistage du cancer au Canada: Ce qui est in, ce qui est out, ce qui sen vient
  • Cancer screening in Canada: Whats in, whats out, whats coming
  • Google Scholar

More in this TOC Section

  • Statin initiation and risk of incident kidney disease in patients with diabetes
  • Acute care related to cannabis use during pregnancy after the legalization of nonmedical cannabis in Ontario
  • Safer opioid supply via a biometric dispensing machine: a qualitative study of barriers, facilitators and associated outcomes
Show more Research

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

CMA Civility, Accessibility, Privacy

 

Powered by HighWire